Raltegravir - C20h21fn6o5, 444.42 Molecular Weight , Antiretroviral Drug For Hiv Treatment

We are engaged in offering excellent quality Raltegravir to our valuable clients.
CAS: 518048-05-0
Molecular formula: C20H21FN6O5
Molecular weight: 444.42

Raltegravir (RAL, Isentress, formerly MK-0518) is an antiretroviral drug produced by Merck & Co., used to treat HIV infection. It received approval by the U.S. Food and Drug Administration (FDA) on 12 October 2007, the first of a new class of HIV drugs, the integrase inhibitors, to receive such approval.
In December 2011, it received FDA approval for pediatric use in patients ages 2a 18, taken in pill form orally twice a day by prescription with two other antiretroviral medications to form the cocktail (most anti-HIV drugs regimens for adults and children use these cocktails). Raltegravir is available in chewable form but- because the two tablet formulations are not interchangeable- the chewable pills are only approved for use in children two to 11. Older adolescents will use the adult formulation. Clients can avail this Raltegravir at industry leading prices from us.